Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus.

Abstract

PURPOSE The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, administration, dosage, place in therapy, and cost of extended-release exenatide are reviewed. SUMMARY Regular-release exenatide has a half-life of 2.4 hours and is administered twice daily. In order to allow for once-weekly administration, exenatide was encapsulated in poly… (More)
DOI: 10.2146/ajhp120168

Topics

Cite this paper

@article{Ryan2013ClinicalEO, title={Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus.}, author={Gina J Ryan and Nader H. Moniri and Dawn D. Smiley}, journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists}, year={2013}, volume={70 13}, pages={1123-31} }